{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urinary-tract-infection-lower-men/prescribing-information/amoxicillin/","result":{"pageContext":{"chapter":{"id":"0998f6ff-17aa-58cd-8188-2fe8d30e2a63","slug":"amoxicillin","fullItemName":"Amoxicillin","depth":2,"htmlHeader":"<!-- begin field 7d09ba63-52aa-4c4e-96ab-a9a100ac3944 --><h2>Amoxicillin</h2><!-- end field 7d09ba63-52aa-4c4e-96ab-a9a100ac3944 -->","summary":"","htmlStringContent":"<!-- begin item 3d6abf6f-e1d6-4072-a49f-a9a100ac385a --><!-- end item 3d6abf6f-e1d6-4072-a49f-a9a100ac385a -->","topic":{"id":"335f7066-6009-52c3-bb1e-bb68e732e41f","topicId":"933b760e-86fa-4ba1-b937-3c052be97e83","topicName":"Urinary tract infection (lower) - men","slug":"urinary-tract-infection-lower-men","lastRevised":"Last revised in November 2018","chapters":[{"id":"a1f0f874-afae-5abc-bfc0-b8aff4687b8d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"722a30e1-802e-50da-aeb2-55a320f811e0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"54bfd7d0-4d24-5c97-b344-6dc7fe0500bf","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d780254d-b3a6-5120-a061-adbfa9d6c3d3","slug":"changes","fullItemName":"Changes"},{"id":"ded6008d-05b8-54a3-9be7-e1f9c635b466","slug":"update","fullItemName":"Update"}]},{"id":"281305b2-29ee-5ee3-879d-2a1c6115b107","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"28ce53d8-a9de-582e-b21f-63a49c9518b7","slug":"goals","fullItemName":"Goals"},{"id":"80a08351-02e8-5bf8-9865-b1f745f759f9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c65e1ea0-2e57-5742-8d13-e19bbdabcf5b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7c3a6d64-9cf2-5b7f-8c66-ac2aa0dab8b9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"edc3c38c-1e69-5da3-8da7-174dd323fee3","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a235fb13-94fa-5fa1-ac15-eae46288950c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f1cf9c73-1a32-5912-8f20-a511a2baa05c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"423dc347-3ec3-514e-bd33-486d46645934","slug":"definition","fullItemName":"Definition"},{"id":"57c35511-4b16-5330-9634-f12fd1accf63","slug":"causes","fullItemName":"Causes"},{"id":"479b7fa1-3b50-51c3-89ac-1373a3aec46a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c6d01476-282e-5662-8378-40f864eedc0e","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"dc3e67c4-09a3-557a-b9d1-7bd1b9692fd3","slug":"complications","fullItemName":"Complications"}]},{"id":"a4c4a87e-e501-53b8-bdd5-15185f853016","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"61ab2e56-53dc-5875-a0bc-41dc08a4b6b8","slug":"suspecting-a-urinary-tract-infection","fullItemName":"Suspecting a urinary tract infection"},{"id":"3f5567ff-0ab4-5228-80d9-6b8addad17e0","slug":"diagnosing-a-urinary-tract-infection","fullItemName":"Diagnosing a urinary tract infection"},{"id":"e65bf3d7-aefc-572c-bf7b-6eb6573d7fb6","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"923818be-e371-5af0-91a7-c470d34dac3c","fullItemName":"Management","slug":"management","subChapters":[{"id":"e3d61967-efe7-54fc-acbd-2e51935ca714","slug":"lower-uti-in-men","fullItemName":"Scenario: Lower UTI in men"},{"id":"f0357d1a-f5ca-5139-ac96-98e285b29c36","slug":"recurrent-uti-in-men","fullItemName":"Scenario: Recurrent UTI in men"},{"id":"88bc8e33-1e01-5b50-b9c2-362bd372238f","slug":"uti-in-men-with-an-indwelling-catheter","fullItemName":"Scenario: UTI in men with an indwelling catheter"}]},{"id":"61acfbd9-7949-528b-b893-b894f9cd6a39","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"0998f6ff-17aa-58cd-8188-2fe8d30e2a63","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"0b85e5c6-7cc0-58a2-8889-5c211efc01d6","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"675b98e1-e1fa-59e0-89d1-0558968a78ba","slug":"nitrofurantoin","fullItemName":"Nitrofurantoin"},{"id":"926ae109-9068-515c-a20f-c9cc8b27eb3b","slug":"pivmecillinam","fullItemName":"Pivmecillinam"}]},{"id":"29b9ddff-7312-54b1-9eae-eefca43a368d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"463fe0f7-80e5-5fcd-9f1c-9c1f76f10f30","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a4e1c5ad-c809-5d8c-ae1c-d37b4f97dd8c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ac4b6d54-2a63-5545-ad06-0abbe7f6354e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1b0a3ea0-682b-5ab3-ae72-bdc7fd586fce","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f7d5ea54-f1b1-59b5-9856-d52f1d73534a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f847f977-daef-5c70-8aa1-eeaf86d9cce7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"235f01e6-f3e2-5784-a197-3b4a11d45527","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"61acfbd9-7949-528b-b893-b894f9cd6a39","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"33056731-9022-509d-a994-20bb082f2626","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 37a5698d-35b7-47aa-850f-a9a100ba076b --><h3>Contraindications and cautions</h3><!-- end field 37a5698d-35b7-47aa-850f-a9a100ba076b -->","summary":"","htmlStringContent":"<!-- begin item 3016fcce-cf02-4e56-a481-a9a100ba06ac --><!-- begin field d2601733-7a2c-4ee6-85cc-a9a100ba076b --><ul><li><strong>Do not prescribe amoxicillin in people with</strong> a true penicillin hypersensitivity.<ul><li>A true penicillin allergy — allergic reactions to penicillins occur in 1–10% of exposed individuals. Anaphylactic reactions occur in fewer than 0.05% of treated patients.</li><li>Gastrointestinal adverse effects alone (for example nausea, vomiting, or diarrhoea) do not constitute an allergy to penicillin. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a> for more information.</li></ul></li><li><strong>Prescribe amoxicillin with caution to people with:</strong><ul><li>Hypersensitivity to cephalosporins.</li><li>Renal impairment — reduce the dose of amoxicillin in severe renal impairment.</li><li>Glandular fever (infective mononucleosis) — these people are especially susceptible to amoxicillin-induced skin rashes.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-men/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-men/references/\">BNF 76, 2018</a>]</p><!-- end field d2601733-7a2c-4ee6-85cc-a9a100ba076b --><!-- end item 3016fcce-cf02-4e56-a481-a9a100ba06ac -->","subChapters":[]},{"id":"8f3e0681-a3a3-586c-9a1c-7189af2233b8","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field d3eed94d-e5c8-404a-9e92-a9a100ba161a --><h3>Adverse effects</h3><!-- end field d3eed94d-e5c8-404a-9e92-a9a100ba161a -->","summary":"","htmlStringContent":"<!-- begin item b9c48408-7845-4cf7-9e9e-a9a100ba15a1 --><!-- begin field 5b7094f6-ef0a-4935-88a7-a9a100ba161a --><ul><li><strong>Gastrointestinal</strong> — nausea and diarrhoea (common), vomiting (uncommon).<ul><li><strong>Very rarely:</strong> antibiotic associated colitis.</li></ul></li><li><strong>Skin</strong> — skin rash (common), urticaria and pruritus (uncommon).<ul><li><strong>Very rarely:</strong> erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis and acute generalised exanthematous pustulosis.</li></ul></li><li>Other very rare adverse effects include:<ul><li>Hepatitis, cholestatic jaundice.</li><li>Hyperkinesia, dizziness, convulsions.</li><li>Interstitial nephritis.</li><li>Leukopenia, thrombocytopenia, haemolytic anaemia.</li><li>Severe allergic reactions.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-men/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-men/references/\">BNF 76, 2018</a>]</p><!-- end field 5b7094f6-ef0a-4935-88a7-a9a100ba161a --><!-- end item b9c48408-7845-4cf7-9e9e-a9a100ba15a1 -->","subChapters":[]},{"id":"e46e1da5-6522-598b-85f8-bd8db4a36970","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 20b7bf61-3894-4d20-9f20-a9a100ba274b --><h3>Drug interactions</h3><!-- end field 20b7bf61-3894-4d20-9f20-a9a100ba274b -->","summary":"","htmlStringContent":"<!-- begin item dd9efe82-758e-4c6d-a359-a9a100ba26c3 --><!-- begin field 823c9aaa-7899-4b7d-9559-a9a100ba274b --><ul><li><strong>Allopurinol</strong> — increased risk of rash when allopurinol is given with amoxicillin. </li><li><strong>Methotrexate</strong> — amoxicillin may reduce methotrexate clearance, causing an increased risk of toxicity.<ul><li>Monitor methotrexate levels more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected.</li></ul></li><li><strong>Oral anticoagulants (warfarin, phenindione)</strong> — INR may be increased. Monitor the international normalized ratio (INR) closely during concomitant use. Dosage adjustments may be necessary.  </li></ul><p> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-men/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-men/references/\">BNF 76, 2018</a>]</p><!-- end field 823c9aaa-7899-4b7d-9559-a9a100ba274b --><!-- end item dd9efe82-758e-4c6d-a359-a9a100ba26c3 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}